Abstract |
Familial dysautonomia (FD) is an autosomal recessive neurodegenerative disorder. The most prevalent causative mutation is a T-->C transition in a donor splice site of the IKBKAP transcript, resulting in aberrant splicing and a truncated protein. The mutation's position and leaky nature suggested that its impact might be moderated by altering the level of splice-regulating proteins. The reported ability of (-)- epigallocatechin gallate (EGCG), a polyphenol, to down-regulate the expression of hnRNP A2/B1, a trans-activating factor that encourages the use of intron-distal 5(') splice sites, prompted an evaluation of its effect on the IKBKAP transcript in FD-derived cells. EGCG reduces the level of hnRNP A2/B1 and increases the amounts of the wild-type IKBKAP-encoded transcript and functional protein. Combined treatment of cells with EGCG and tocotrienol, which upregulates IKBKAP transcription, results in a synergistic production of the functional gene product. These findings suggest the possible use of EGCG as a therapeutic modality for individuals with FD.
|
Authors | Sylvia L Anderson, Jinsong Qiu, Berish Y Rubin |
Journal | Biochemical and biophysical research communications
(Biochem Biophys Res Commun)
Vol. 310
Issue 2
Pg. 627-33
(Oct 17 2003)
ISSN: 0006-291X [Print] United States |
PMID | 14521957
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Carrier Proteins
- Elp1 protein, human
- Heterogeneous-Nuclear Ribonucleoprotein Group A-B
- RNA, Messenger
- Tocotrienols
- Transcriptional Elongation Factors
- Catechin
- epigallocatechin gallate
|
Topics |
- Base Sequence
- Carrier Proteins
(genetics, metabolism)
- Catechin
(analogs & derivatives, pharmacology)
- Cell Line
- Drug Synergism
- Dysautonomia, Familial
(genetics, metabolism)
- Heterogeneous-Nuclear Ribonucleoprotein Group A-B
(genetics, metabolism)
- Humans
- Molecular Sequence Data
- Mutation
- RNA Splicing
(drug effects)
- RNA, Messenger
(chemistry, metabolism)
- Tocotrienols
(pharmacology)
- Transcriptional Elongation Factors
|